This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Sulphasalazine

Authoring team

Sulphasalazine is an aminosalicylate which is mainly used in the treatment of ulcerative colitis - the induction and maintenance of remission - and the treatment of active Crohn's disease.

Sulphasalazine is constructed from sulphonamide (sulphapyridine) bonded to 5-aminosalicylic acid, 5-ASA, of which the latter is the active moiety, but needs to be linked to another molecule to be absorbed. This compound is probably acting locally.

The summary of product characteristics should be consulted before prescribing this drug.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.